Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Liabilities and Shareholders Equity (2022 - 2023)

Historic Liabilities and Shareholders Equity for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $54.7 million.

  • Lexeo Therapeutics' Liabilities and Shareholders Equity changed N/A to $54.7 million in Q3 2023 from the same period last year, while for Dec 2023 it was $54.7 million, marking a year-over-year change of. This contributed to the annual value of $97.1 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Lexeo Therapeutics' Liabilities and Shareholders Equity stood at $54.7 million.
  • Lexeo Therapeutics' Liabilities and Shareholders Equity's 5-year high stood at $97.1 million during Q4 2022, with a 5-year trough of $54.7 million in Q3 2023.